The invention
Secreted CDCP1 as a Novel Blood-borne Biomarker for Noninvasive Diagnosis and Precision Treatment of Nonalcoholic Steatohepatitis (NASH)
The invention
- Name of invention
- Secreted CDCP1 as a Novel Blood-borne Biomarker for Noninvasive Diagnosis and Precision Treatment of Nonalcoholic Steatohepatitis (NASH)
- La sécrétion de CDCP1 en tant que nouveau biomarqueur sanguin pour le diagnostic non invasif et le traitement de précision de la stéatohépatite non alcoolique (NASH)
Invention description
- Description
- We discovered sCDCP1 as a robust biomarker for NASH (the most common chronic liver disease) and developed an ultrasensitive sCDCP1 assay for noninvasive diagnosis of NASH, and a sCDCP1 siRNA nanodrug for treatment of NASH with excellent efficacy.
- Video
- Link
INVENTORS
Aimin XU inventor 3727293030_3315
The University of Hong Kong inventor 3727293030_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.